WallStreetZenWallStreetZen

NASDAQ: ALVO
Alvotech Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ALVO stock forecasts and price targets.

ALVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-14

1 of 1

Forecast return on equity

Is ALVO forecast to generate an efficient return?

Company
N/A
Industry
30.28%
Market
89.75%

Forecast return on assets

Is ALVO forecast to generate an efficient return on assets?

Company
N/A
Industry
15.27%

ALVO earnings per share forecast

What is ALVO's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.17-58.63%
Avg 2 year Forecast
$0.81+97.02%
Avg 3 year Forecast
$0.83+102.95%
ALVO's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ALVO revenue forecast

What is ALVO's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$651.6M+10.84%
Avg 2 year Forecast
$853.9M+45.25%
Avg 3 year Forecast
$1.3B+117.9%
ALVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALVO earnings growth forecast

How is ALVO forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
35.33%
Industry
26.37%
Market
15.81%
ALVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ALVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ALVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ALVO revenue growth forecast

How is ALVO forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
27.44%
Industry
4.27%
Market
10.38%
ALVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALVO vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ALVO$8.74N/AN/A
AMRX$8.33$11.50+38.06%Strong Buy
BHC$6.59$9.00+36.57%Hold
HCM$16.30N/AN/A
INDV$15.14$17.50+15.59%Strong Buy
View Top Pharmaceutical Stocks

Alvotech Stock Forecast FAQ

What is ALVO's earnings growth forecast for 2025-2027?

(NASDAQ: ALVO) Alvotech's forecast annual earnings growth rate of 35.33% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 26.37%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.81%.

Alvotech's earnings in 2025 is $96,545,000.On average, 3 Wall Street analysts forecast ALVO's earnings for 2025 to be $51,186,243, with the lowest ALVO earnings forecast at -$42,584,781, and the highest ALVO earnings forecast at $178,065,349. On average, 2 Wall Street analysts forecast ALVO's earnings for 2026 to be $243,798,626, with the lowest ALVO earnings forecast at $74,093,294, and the highest ALVO earnings forecast at $413,473,777.

In 2027, ALVO is forecast to generate $251,132,504 in earnings, with the lowest earnings forecast at $251,132,504 and the highest earnings forecast at $251,132,504.

If you're new to stock investing, here's how to buy Alvotech stock.

What is ALVO's revenue growth forecast for 2025-2027?

(NASDAQ: ALVO) Alvotech's forecast annual revenue growth rate of 27.44% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.27%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.38%.

Alvotech's revenue in 2025 is $587,890,000.On average, 2 Wall Street analysts forecast ALVO's revenue for 2025 to be $196,669,254,972, with the lowest ALVO revenue forecast at $191,646,604,895, and the highest ALVO revenue forecast at $201,692,206,854. On average, 2 Wall Street analysts forecast ALVO's revenue for 2026 to be $257,715,187,453, with the lowest ALVO revenue forecast at $230,806,495,097, and the highest ALVO revenue forecast at $284,623,879,808.

In 2027, ALVO is forecast to generate $386,616,090,294 in revenue, with the lowest revenue forecast at $386,616,090,294 and the highest revenue forecast at $386,616,090,294.

What is ALVO's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ALVO) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.27%.

What is ALVO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ALVO) Alvotech's current Earnings Per Share (EPS) is $0.41. On average, analysts forecast that ALVO's EPS will be $0.17 for 2025, with the lowest EPS forecast at -$0.14, and the highest EPS forecast at $0.59. On average, analysts forecast that ALVO's EPS will be $0.81 for 2026, with the lowest EPS forecast at $0.25, and the highest EPS forecast at $1.37. In 2027, ALVO's EPS is forecast to hit $0.83 (min: $0.83, max: $0.83).

What is ALVO's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ALVO) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.